COSMOS Pharmaceutical Corporation (CSMYF)
USD 46.06
(-0.22%)
USD 46.06
(-0.22%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 245.1 Billion JPY | 16.78% |
| 2023 | 209.89 Billion JPY | 21.65% |
| 2022 | 172.54 Billion JPY | 1.06% |
| 2021 | 170.74 Billion JPY | -2.22% |
| 2020 | 174.6 Billion JPY | 18.56% |
| 2019 | 147.27 Billion JPY | 3.92% |
| 2018 | 141.72 Billion JPY | 6.85% |
| 2017 | 132.63 Billion JPY | 4.92% |
| 2016 | 126.41 Billion JPY | 21.71% |
| 2015 | 103.86 Billion JPY | 17.62% |
| 2014 | 88.3 Billion JPY | 25.08% |
| 2013 | 70.59 Billion JPY | 11.9% |
| 2012 | 63.08 Billion JPY | 16.2% |
| 2011 | 54.29 Billion JPY | 10.4% |
| 2010 | 49.18 Billion JPY | 9.53% |
| 2009 | 44.9 Billion JPY | 22.42% |
| 2008 | 36.67 Billion JPY | 27.46% |
| 2007 | 28.77 Billion JPY | 17.2% |
| 2006 | 24.55 Billion JPY | 11.74% |
| 2005 | 21.97 Billion JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 205.95 Billion JPY | -4.32% |
| 2024 Q4 | 245.1 Billion JPY | 19.01% |
| 2024 FY | 245.1 Billion JPY | 16.77% |
| 2024 Q2 | 215.26 Billion JPY | -2.07% |
| 2024 Q1 | 219.82 Billion JPY | 4.73% |
| 2023 Q3 | 173.4 Billion JPY | -2.94% |
| 2023 FY | 209.89 Billion JPY | 21.65% |
| 2023 Q4 | 209.89 Billion JPY | 21.05% |
| 2023 Q2 | 178.65 Billion JPY | 0.43% |
| 2023 Q1 | 177.89 Billion JPY | 3.1% |
| 2022 Q4 | 172.54 Billion JPY | 8.07% |
| 2022 Q3 | 159.65 Billion JPY | -3.81% |
| 2022 FY | 172.54 Billion JPY | 1.06% |
| 2022 Q1 | 168.49 Billion JPY | -1.31% |
| 2022 Q2 | 165.98 Billion JPY | -1.49% |
| 2021 Q4 | 170.74 Billion JPY | 10.69% |
| 2021 Q1 | 163.36 Billion JPY | -6.44% |
| 2021 Q3 | 154.24 Billion JPY | -2.22% |
| 2021 Q2 | 157.75 Billion JPY | -3.44% |
| 2021 FY | 170.74 Billion JPY | -2.22% |
| 2020 Q4 | 174.6 Billion JPY | 21.79% |
| 2020 FY | 174.6 Billion JPY | 18.56% |
| 2020 Q1 | 143.48 Billion JPY | -2.57% |
| 2020 Q2 | 144.74 Billion JPY | 0.88% |
| 2020 Q3 | 143.36 Billion JPY | -0.95% |
| 2019 Q1 | 139.58 Billion JPY | -1.51% |
| 2019 Q4 | 147.27 Billion JPY | 5.09% |
| 2019 FY | 147.27 Billion JPY | 3.92% |
| 2019 Q2 | 138.02 Billion JPY | -1.12% |
| 2019 Q3 | 140.13 Billion JPY | 1.53% |
| 2018 FY | 141.72 Billion JPY | 6.85% |
| 2018 Q2 | 134.39 Billion JPY | 0.61% |
| 2018 Q1 | 133.57 Billion JPY | 0.71% |
| 2018 Q4 | 141.72 Billion JPY | 6.39% |
| 2018 Q3 | 133.21 Billion JPY | -0.88% |
| 2017 Q4 | 132.63 Billion JPY | 9.96% |
| 2017 FY | 132.63 Billion JPY | 4.92% |
| 2017 Q3 | 120.62 Billion JPY | -3.6% |
| 2017 Q2 | 125.12 Billion JPY | -0.21% |
| 2017 Q1 | 125.38 Billion JPY | -0.82% |
| 2016 Q1 | 104.39 Billion JPY | 0.51% |
| 2016 FY | 126.41 Billion JPY | 21.71% |
| 2016 Q4 | 126.41 Billion JPY | 9.73% |
| 2016 Q3 | 115.2 Billion JPY | -2.7% |
| 2016 Q2 | 118.4 Billion JPY | 13.42% |
| 2015 Q2 | 93.08 Billion JPY | -3.1% |
| 2015 Q3 | 100.95 Billion JPY | 8.44% |
| 2015 Q4 | 103.86 Billion JPY | 2.89% |
| 2015 FY | 103.86 Billion JPY | 17.62% |
| 2015 Q1 | 96.06 Billion JPY | 8.79% |
| 2014 Q2 | 75.11 Billion JPY | 7.03% |
| 2014 Q3 | 76.67 Billion JPY | 2.08% |
| 2014 FY | 88.3 Billion JPY | 25.08% |
| 2014 Q1 | 70.18 Billion JPY | -0.59% |
| 2014 Q4 | 88.3 Billion JPY | 15.16% |
| 2013 Q4 | 70.59 Billion JPY | 19.62% |
| 2013 Q2 | 67.36 Billion JPY | 7.5% |
| 2013 FY | 70.59 Billion JPY | 11.9% |
| 2013 Q1 | 62.66 Billion JPY | -0.67% |
| 2013 Q3 | 59.01 Billion JPY | -12.4% |
| 2012 FY | 63.08 Billion JPY | 16.2% |
| 2012 Q3 | 53.39 Billion JPY | -6.41% |
| 2012 Q2 | 57.05 Billion JPY | 4.13% |
| 2012 Q4 | 63.08 Billion JPY | 18.15% |
| 2012 Q1 | 54.79 Billion JPY | 0.92% |
| 2011 Q2 | 50.42 Billion JPY | 0.11% |
| 2011 FY | 54.29 Billion JPY | 10.4% |
| 2011 Q4 | 54.29 Billion JPY | 13.85% |
| 2011 Q3 | 47.68 Billion JPY | -5.42% |
| 2011 Q1 | 50.36 Billion JPY | 2.41% |
| 2010 Q3 | 43.84 Billion JPY | 0.0% |
| 2010 FY | 49.18 Billion JPY | 9.53% |
| 2010 Q4 | 49.18 Billion JPY | 12.17% |
| 2009 Q3 | 39.36 Billion JPY | -1.41% |
| 2009 FY | 44.9 Billion JPY | 22.42% |
| 2009 Q2 | 39.92 Billion JPY | 0.0% |
| 2009 Q4 | 44.9 Billion JPY | 14.07% |
| 2008 FY | 36.67 Billion JPY | 27.46% |
| 2007 FY | 28.77 Billion JPY | 17.2% |
| 2006 FY | 24.55 Billion JPY | 11.74% |
| 2005 FY | 21.97 Billion JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | 3.15 Million USD | -7772716.501% |
| Allstar Health Brands, Inc. | 9.3 Million USD | -2634358.97% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 52.97 Million USD | -462589.973% |
| Café Serendipity Holdings, Inc. | 1.31 Million USD | -18599029.312% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | 543.26 Thousand USD | -45116353.725% |
| HealthWarehouse.com, Inc. | 7.21 Million USD | -3397158.641% |
| LIGAND PHARMACEUTICAL INC | 86.3 Million USD | -283900.556% |
| MedGen, Inc. | 43.63 USD | -561771716608.687% |
| Omni Health, Inc. | 1.94 Million USD | -12623443.869% |
| Oxford Investments Holdings Inc. | 1.01 Million USD | -24096739.208% |
| Pineapple, Inc. | 10.61 Million USD | -2308482.466% |
| ScripsAmerica, Inc. | 9.16 Million USD | -2673575.865% |